A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Type I-Polarized Autologous Dendritic Cell Vaccine With Tumor Blood Vessel Antigen-Derived Peptides in Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study for Solid Metastatic Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Study of ESR1 Mutations in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- NA
Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE4
SOLTI Breast Cancer Molecular Screening Program (AGATA)
- Status
- COMPLETED
- Phase
- N/A
Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor
- Status
- COMPLETED
- Phase
- NA
Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC
- Status
- COMPLETED
- Phase
- N/A
A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- Status
- RECRUITING
- Phase
- PHASE2
Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens
- Status
- COMPLETED
- Phase
- PHASE2
[18F]FES PET/CT in Endocrine Refractory Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Overcoming Endocrine Resistance in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Retroprospective Real Life Observatory of Eribulin
- Status
- COMPLETED
- Phase
- N/A
A Pilot Dose Escalation Trial of a Densified Chemotherapy Association of Docetaxel and Epirubicin Driven by Mathematical Modeling in Metastatic Breast Cancer Patients: The MODEL1 Study
- Status
- COMPLETED
- Phase
- PHASE1